Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-beta (Abeta) peptide. Solanezumab has the potential for the research of Alzheimers disease.
Purity:
>99.0%
CAS Number:
[955085-14-0]
* VAT and and shipping costs not included. Errors and price changes excepted